Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Elevance Health, Inc. Common Stock (NY:ELV)

347.84 -2.41 (-0.69%)
Official Closing Price Updated: 1:10 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
ELV COURT NEWS: Elevance Health, Inc. was Sued for Securities Fraud -- Investors are Urged to Contact BFA Law by July 11 Legal Deadline
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
Via ACCESS Newswire
UnitedHealth Stock Touted For 36% Gain? JPMorgan Points To Medicare Advantage Margin Tailwind
The research firm expects lower enrollment growth as UnitedHealth exits unprofitable plans and prioritizes margin discipline. 
Via Stocktwits
Topics Government
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV
From The Rosen Law Firm PA
Via GlobeNewswire
Looking Into Elevance Health's Recent Short Interest
Via Benzinga
Beyond The Numbers: 9 Analysts Discuss Elevance Health Stock
Via Benzinga
3 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
ELV COURT NOTICE: Lose Money on Elevance Health, Inc.? Contact BFA Law before Upcoming Class Action Deadline
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
From Pomerantz LLP
Via GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
ELV NOTIFICATION: Elevance Health, Inc. Shareholders are Notified of The Ongoing Securities Fraud Class Action Lawsuit - Contact BFA Law by July 11
Via ACCESS Newswire
Senate Bill Tightens Medicaid Rules: Humana, Cigna, CVS See Medicare Relief
The draft Senate bill introduces stricter work requirements and funding curbs for Medicaid, while shelving proposed Medicare cuts that could have impacted major insurers. 
Via Stocktwits
Topics Government
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ELV SHAREHOLDER ALERT: BFA Law Reminds Elevance Health, Inc. Investors of Upcoming July 11 Class Action Deadline - Contact The Firm if You Suffered Losses
Via ACCESS Newswire
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Elevance Health (NYSE:ELV) and... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
From Pomerantz LLP
Via GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV
From The Rosen Law Firm PA
Via GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance
From Faruqi & Faruqi LLP
Via GlobeNewswire
$1000 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Elevance Health (ELV): Buy, Sell, or Hold Post Q1 Earnings?
Since December 2024, Elevance Health has been in a holding pattern, floating around $383.92. 
Via StockStory
Topics Government Supply Chain
Recent Filing Shows That Rep. Robert Bresnahan Bought Over $28K Worth of AbbVie Stock
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
From Pomerantz LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Digimarc, Elevance Health, and Iovance and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
2 Cash-Producing Stocks with Solid Fundamentals and 1 to Approach with Caution
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
From Pomerantz LLP
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance
From Faruqi & Faruqi LLP
Via GlobeNewswire
Humana Backs Reforms To Limit Medicare Advantage Billing Practices
Humana is joining lawmakers in support of limiting Medicare Advantage payments tied to home visit diagnoses. 
Via Benzinga
NYSE: ELV DEADLINE REMINDER: Berger Montague Reminds Elevance Health (NYSE: ELV) Investors of Important Class Action Lawsuit Deadline
From Berger Montague
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance Health, and Iovance and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
From Pomerantz LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.